164
Views
1
CrossRef citations to date
0
Altmetric
Review

The autonomic nervous system and renal physiology

&
Pages 149-160 | Published online: 30 Aug 2013

References

  • EslerMThe sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. The Paton Lecture 2010Exp Physiol201196761162221551268
  • von EulerUSA specific sympathetic ergone in adrenergic nerve fibers (sympathin) and its relation to adrenalin and noradrenalinActa Physiol Scand1946127396
  • von EulerUSHellnerSPurkholdAExcretion of noradrenaline in urine in hypertensionScandinavian Journal of Clinical and Laboratory Investigation195461545913186788
  • WillisTAn illustration of human sympathetic nerves of neck and thoraxZimmerCSoul Made FleshLondonRandom House (Arrow Books)2004187207
  • CannonWBNewtonHFBrightEMMenkinVMooreRMSome aspects of the physiology of animals surviving complete exclusion of sympathetic nerve impulsesAm J Physiol192989184107
  • DiBonaGFNeural control of the kidney: functionally specific renal nerve fibers. The Starling LectureAm J Physiol Regul Integr Comp Physiol2000279R1517R152411049831
  • DiBonaGFKoppUCNeural control of renal functionPhysiological Reviews1997771751979016301
  • DiBonaGFNeurogenic regulation of renal tubular sodium reabsorptionAm J Physiol19772332F73F81329687
  • DiBonaGFSawinLLRenal nerves in renal adaptation to dietary sodium restrictionAm J Physiol19832453F322F3286614170
  • DiBonaGFSawinLLRenal nerve activity in conscious rats during volume expansion and depletionAm J Physiol19852481 Pt 2F15F233970162
  • DiBonaGFSawinLLEffect of renal nerve stimulation on NaCl and H2O in Henle’s loop of the ratAm J Physiol19822436F576F5807149026
  • OsbornJLDiBonaGFThamesMDBeta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulationJ Pharmacol Exp Ther198121622652696257884
  • NollGWenzelRRSchneiderMIncreased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parentsCirculation19969358668698598076
  • de Almeida Chaves RodriguesAFde LimaILBergamaschiCTIncreased renal sympathetic nerve activity leads to hypertension and renal dysfunction in offspring from diabetic mothersAm J Physiol Renal Physiol20133042F189F19723136005
  • FerrierCJenningsGLEisenhoferGEvidence for increased noradrenalin release from subcortical brain regions in essential hypertensionJ Hypertens19931111121712278301103
  • DaileyGBodenGCreechRJohnsonDGleasonREKennedyFPWeinrauchLAWeirMD’EliaJEffects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathyMetabolism200049111491149511092517
  • WeinrauchLAD’EliaJAGleasonREKeoughJMannDKennedyFPAutonomic function in type 1 diabetes mellitus complicated by nephropathy. A cross-sectional analysis in the presymptomatic phaseAm J Hypertens1995887827897576394
  • WeinrauchLAKennedyFJBurgerAGleasonREKeoughJD’EliaJAProspective evaluation of autonomic dysfunction in aggressive management of diabetic microangiopathyAm J Hypertens19991211 Pt 11135113910604492
  • BurgerAJWeinrauchLAD’EliaJAAronsonDEffects of glycemic control on heart rate variability in type 1 diabetic patients with cardiac autonomic neuropathyAm J Cardiol199984668769110498140
  • AepfelbacherFYeonSBWeinrauchLAD’EliaJBurgerAJEffect of improved glycemic control on left ventricular structure and function in patients with Type 1 diabetes mellitusIntl J Cardiol2004944751
  • WeinrauchLAKennedyFPGleasonREKeoughJD’EliaJARelationship between autonomic function and the progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure controlAm J Hypertens1998113 Pt 13023089544870
  • RoshanBToferGWeinrauchLGleasonRKeoughJLipinskaILeeATD’EliaJImproved glycemic control and platelet function abnormalities in diabetic patients with microvascular diseaseMetabolism2000491889110647069
  • LohmeierTEIllescuRChronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapyHypertension201157588088621357283
  • EckbergDLDrabinskyMBraunwaldEDefective cardiac parasympathetic control in patients with heart diseaseN Engl J Med1971285168778834398792
  • HaynesWGMorganDADjalaliASivitzWIMarkALInteractions between the melanocortin system and leptin in control of sympathetic nerve trafficHypertension1999331 Pt 25425479931162
  • SchlingPMallowHTrindlALöfferGEvidence for a local renin angiotensin system in primary cultured human preadipocytesInt J Obes Relat Metab Disord199923433634110340809
  • AbumradNAPerryPRWhitesellRRStimulation by epinephrine of the membrane transport of long chain fatty acid in the adipocyteJ Biol Chem198526018996999714019520
  • GoodfriendTLBallDLEganBMCampbellWBNithipatikomKEpoxy-keto derivative of linoleic acid stimulates aldosterone secretionHypertension200443235836314718355
  • Ehrhart-BornsteinMLamounier-ZepterVSchravenAHuman adipocytes secrete mineralocorticoid-releasing factorsProc Natl Acad Sci U S A200310024142111421614614137
  • GreensteinASKhavandiKWithersSBLocal inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patientsCirculation2009119121661167019289637
  • Yamada-GotoNKatsuuraGEbiharaKIntracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in miceDiabetes20136251500150423274904
  • BoloNRMusenGJacobsonAMBrain activation during working memory is altered in patients with type 1 diabetes during hypoglycemiaDiabetes201160123256326421984582
  • SommersSCRelmanASSmithwickRHHistologic studies of kidney biopsy specimens from patients with hypertensionAm J Pathol195834468571513559400
  • DiBonaGFSawinLLReflex regulation of renal nerve activity in cardiac failureAm J Physiol19942661 Pt 2R27R398304550
  • ParmleyWWBraunwaldEComparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidineJ Pharmacol Exp Ther1967158111216054071
  • SwedbergKViqueratCRouleauJLComparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failureAm J Cardiol19845477837866486028
  • VogelJHJacobowitzDChidseyCADistrubution of norepinephrine in the failing bovine heart. Correlation of chemical analysis and fluorescene microscopyCirc Res196924171845763740
  • VogelJHChidseyCACardiac adrenergic activity in experimental heart failure assessed with beta receptor blockadeAm J Cardiol19692421982084240507
  • GaffneyTEBraunwaldEImportance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failureAm J Med19633432032413946093
  • FrancisGSGoldsmithSRZiescheSMCohnJNResponse of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failureAm J Cardiol1982495115211567064841
  • SwedbergKHjalmarsonAWaagsteinFWallentinIProlongation of survival in congestive cardiomyopathy by beta-receptor blockadeLancet1979181311374137687834
  • WaagsteinFHjalmarsonAVarnauskasEWallentinIEffect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathyBr Heart J19753710102210361191416
  • ParatiGEslerMThe human sympathetic nervous system: its relevance in hypertension and heart failureEur Heart J20123391058106622507981
  • EslerMStraznickyNEikelisNMasuoKLambertGLambertEMechanisms of sympathetic activation in obesity-related hypertensionHypertension200648578779617000932
  • MaynardSEMinJYMerchanJExcess placental soluble fms-like tyrosine kinase 1 (sFlt) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJ Clin Invest2003111564965812618519
  • MaynardSEpsteinFHKarumanchiSAPreeclampsia and angiogenic imbalanceAnnu Rev Med200859617817937587
  • NewellJLSmithwickRHPregnancy following lumbodorsal splanchnicectomy for essential and malignant hypertension and hypertension associated with chronic pyelonephritisN Engl J Med19472362385185820241256
  • HaringtonMKincaid-SmithPMcMichaelJResults of treatment of malignant hypertension: a seven-year experience in 94 casesBr Med J19592515896998014399810
  • CastlemanBSmithwickRHThe relation of vascular disease to the hypertensive state; the adequacy of renal biopsy as determined from a study of 500 patientsN Engl J Med19482392072973218892586
  • DiBonaGFEslerMTranslational medicine: the antihypertensive effect of renal denervationAm J Physiol Regul Integr Comp Physiol20102982R245R25319955493
  • NagasuHSatohMKuwabaraARenal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive ratsNephrol Dial Transplant20102592889289820299340
  • GenoveseGTonnaSJKnobAUA risk allele for focal segmental glomerulosclerosis in African-Americans is located within a region containing APOL1 and MYH9Kidney Int2010787698704
  • KimJPadanilamBJRenal nerves drive interstitial fibrogenesis in obstructive uropathyJ Am Soc Nephrol201324222924223264683
  • ScheffersIJKroonAASchmidliJNovel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility studyJ Am Coll Cardiol201056151254125820883933
  • GrossmanEMesserliFHEffect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressureAm J Cardiol19978011145314589399721
  • GiudicelliJFBerdeauxAEdouardARicherCJacolotDThe effect of enalapril on baroreceptor mediated reflex function in normotensive subjectsBr J Clin Pharmacol19852032112182994702
  • GuthrieGPJrKotchenTAEffects of prazosin and clonidine on sympathetic and baroreflex function in patients with essential hypertensionJ Clin Pharmacol1983238–93483546630584
  • CalhounDAJonesDTextorSAmerican Heart Association Professional Education CommitteeResistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure ResearchCirculation200811725e510e52618574054
  • PersellSDPrevalence of resistant hypertension in the United States 2003–2008Hypertension20115761076108021502568
  • AldermanMHResistant hypertension: a clinical syndrome in search of a definitionAm J Hypertens200821996596618725879
  • EganBMZhaoYAxonRNBrezinskiWAFerdinandKCUncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008Circulation201112491046105821824920
  • NagaseMMatsuiHShibataSGotodaTFujitaTSalt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor. Role of oxidative stressHypertension200750587788317875821
  • de la SierraABanegasJROliverasAClinical differences between resistant hypertensives and patients treated and controlled with three or fewer drugsJ Hypertens20123061211121622525201
  • De NicolaLGabbaiFBAgarwalRPrevalence and prognostic role of resistant hypertension in chronic kidney disease patientsJ Am Coll Cardiol201361242461246723623908
  • IimuroSImaiEWatanabeTChronic Kidney Disease Japan Cohort Study GroupClinical correlates of ambulatory BP monitoring among patients with CKDClin J Am Soc Nephrol20138572173023411432
  • WeinrauchLADesaiASSkaliHD’EliaJARisk stratification of resistant hypertension in chronic kidney diseaseJ Am Coll Cardiol201361242468247023623913
  • RahmanMFordCECutlerJAALLHAT Collaborative Research GroupLong-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFRClin J Am Soc Nephrol201276989100222490878
  • LaurentSSchlaichMEslerMNew drugs, procedures, and devices for hypertensionLancet201238059160022883508
  • TamGMYanBPShettySVLamYYTranscatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisitedInt J Cardiol2013164327728122336259
  • ProchnauDFigullaHRSurberRCryoenergy is effective in the treatment of resistant hypertension in non-responders to radiofrequency renal denervationInt J Cardiol2013167258859023098851
  • SavardSFrankMBobrieGPlouinPFSapovalMAziziMEligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patientsJ Am Coll Cardiol201260232422242423141491
  • Symplicity HTN-2 InvestigatorsEslerMDKrumHSobotkaPARenal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialLancet201037697561903190921093036
  • HeringDMahfoudFWaltonASRenal denervation in moderate to severe CKDJ Am Soc Nephrol20122371250125722595301
  • BrinkmannJHeusserKSchmidtBMCatheter-based nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case seriesHypertension20126061485149023045466
  • HarrisonLHJrFlyeMWSeiglerHFIncidence of anatomical variants in renal vasculature in the presence of normal renal functionAnn Surg197818818389352280
  • SabaLSanfilippoRMontisciRContiMMallariniGAccessory renal artery stenosis and hypertension: are these correlated? Evaluation using multidetector-row computed tomographic angiographyActa Radiol200849327828418365815
  • MahfoudFLüscherTFAnderssonBExpert consensus document from the European Society of Cardiology on catheter-based renal denervationEur Heart J Epub6252013
  • WangQGuoRRongSNoninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a preclinical canine modelJ Am Coll Cardiol201361212185219223541964
  • StevensPELevinAKidney Disease: improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group MembersEvaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guidelineAnn Intern Med20131581182583023732715